Qingrou Wang

Ruijin Hospital

Papers

1

Total Citations

8

H-Index

1

About

Dr. Qingrou Wang is a pioneering robotic surgeon whose work centers on advancing minimally invasive pancreatic surgery, particularly for benign and low-grade malignant tumors. Her major contribution lies in rigorously comparing surgical techniques to optimize patient outcomes. In her landmark propensity score-matched study, she demonstrated that robot-assisted middle pancreatectomy (RMP) offers superior preservation of pancreatic function compared to robot-assisted distal pancreatectomy (RDP) for tumors located in the pancreatic neck, without compromising oncological safety. This work, which has garnered 8 citations, provides critical evidence guiding surgical decision-making for a challenging patient population. By analyzing data from over 800 patients, Dr. Wang has helped establish RMP as a viable, parenchyma-sparing alternative, reducing the risk of postoperative endocrine and exocrine insufficiency. Her research directly impacts the quality of life for patients with low-grade malignancies, showcasing her commitment to balancing curative resection with functional preservation. Dr. Wang’s expertise in robotic techniques positions her at the forefront of precision surgery, making her a key figure in the evolution of pancreatic cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Comparison between robot‐assisted middle pancreatectomy and robot‐assisted distal pancreatectomy for benign or low‐grade malignant tumours located in the neck of the pancreas: A propensity score matched study
8 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Ruijin Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago